Application 076830
- Type
- ANDA
- Sponsor
- ALVOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OFLOXACIN | OFLOXACIN | SOLUTION/DROPS;OPHTHALMIC | 0.3% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076830-001 | OFLOXACIN | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2004-08-31 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2004-08-31 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2004-08-31 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2004-08-31 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2004-08-31 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2004-08-31 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A076830-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | 2004-08-31 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A076830-001 | AT | 1 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | A076830-001 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A076830-001 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A076830-001 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A076830-001 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A076830-001 | AT | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OFLOXACIN | OFLOXACIN | Redpharm Drug | 37456656-77c8-d74c-e063-6294a90ab729 | 2025-12-13 | Warnings, Adverse reactions | OFLOXACIN OFLOXACIN |
| Ofloxacin | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | SOLA Pharmaceuticals, LLC | 4ca27244-ed70-4868-b2d8-8f97c3a52148 | 2025-12-08 | Warnings, Adverse reactions | Ofloxacin |
| Ofloxacin | OFLOXACIN | Redpharm Drug | 3dd035d0-c3ec-3fc2-e063-6294a90a4aac | 2025-12-02 | Warnings, Adverse reactions | Ofloxacin OFLOXACIN |
| ofloxacin | OFLOXACIN | NuCare Pharmaceuticals, Inc. | 4484283c-7839-e75d-e063-6394a90a8639 | 2025-11-26 | Warnings, Adverse reactions | ofloxacin OFLOXACIN |
| ofloxacin | OFLOXACIN | A-S Medication Solutions | 8fd1eba2-2ed2-40a8-ae10-957b07434fe5 | 2025-11-12 | Warnings, Adverse reactions | ofloxacin OFLOXACIN |
| Ofloxacin Otic | OFLOXACIN | Bryant Ranch Prepack | 7ba2d774-27d8-4ee0-9ef3-cc4900dcc5fa | 2025-10-30 | Warnings, Adverse reactions | OFLOXACIN |
| Ofloxacin | OFLOXACIN | A-S Medication Solutions | ab5b0e34-ac5c-4c0c-b104-934b319ae011 | 2025-08-15 | Warnings, Adverse reactions | Ofloxacin OFLOXACIN |
| Ofloxacin | OFLOXACIN | Bausch & Lomb Incorporated | ad40954d-0b1d-47c5-8bd5-8a1efd9a7153 | 2025-06-12 | Warnings, Adverse reactions | Ofloxacin OFLOXACIN |
| Ofloxacin | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | Caplin Steriles Limited | 53f7ec2e-5b4c-4f8c-b8ba-7f8844e0c01b | 2025-02-05 | Warnings, Adverse reactions | Ofloxacin |
| Ofloxacin Otic | OFLOXACIN | NuCare Pharmaceuticals,Inc. | 76f461da-0e15-aa6d-e053-2a91aa0a9808 | 2024-12-26 | Warnings, Adverse reactions | OFLOXACIN |
| Ofloxacin | OFLOXACIN | NuCare Pharmaceuticals, Inc. | 51f3d155-36df-4c40-e054-00144ff8d46c | 2024-12-24 | Warnings, Adverse reactions | Ofloxacin OFLOXACIN |
| ofloxacin | OFLOXACIN | Lifestar Pharma LLC | 871d63f4-41c1-4b30-903c-11fbf0d4c1f8 | 2024-12-23 | Warnings, Adverse reactions | ofloxacin OFLOXACIN |
| Ofloxacin | OFLOXACIN OTIC | Caplin Steriles Limited | 2bb61a24-87a6-4e74-a319-fc5e7c483bbb | 2024-12-16 | Warnings, Adverse reactions | Ofloxacin |
| ofloxacin | OFLOXACIN | Major Pharmaceuticals | 2d7a1f80-1c59-49e6-aff7-aedacade2dd6 | 2024-11-12 | Warnings, Adverse reactions | ofloxacin OFLOXACIN |
| Ofloxacin | OFLOXACIN | Somerset Therapeutics, LLC | 72ad7b86-1d5b-48c9-bb40-319d6c186f1d | 2024-10-31 | Warnings, Adverse reactions | Ofloxacin OFLOXACIN |
| Ofloxacin | OFLOXACIN | A-S Medication Solutions | 1838671d-e312-442a-b0bc-6702d6a8965c | 2024-10-14 | Warnings, Adverse reactions | Ofloxacin OFLOXACIN |
| Ofloxacin | OFLOXACIN | Somerset Therapeutics, LLC | 4b2b893d-c19b-4c4a-85de-ff901325080b | 2024-10-11 | Warnings, Adverse reactions | Ofloxacin OFLOXACIN |
| Ofloxacin Otic | OFLOXACIN | Bryant Ranch Prepack | 4f4048b2-3ae8-441a-b1e3-7311fac00f94 | 2024-09-20 | Warnings, Adverse reactions | OFLOXACIN |
| Ofloxacin Otic | OFLOXACIN | Bryant Ranch Prepack | 567fa672-5fd0-4a1d-bc12-054a9ac16117 | 2024-09-19 | Warnings, Adverse reactions | OFLOXACIN |
| OFLOXACIN | OFLOXACIN | Cadila Pharmaceuticals Limited | c677b35c-0432-4ee5-af57-1f95449c48b6 | 2024-09-12 | Boxed warning, Warnings, Adverse reactions | OFLOXACIN OFLOXACIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0517-0760 | Ofloxacin | Ofloxacin | American Regent, Inc. | ANDA | Current |